News Focus
News Focus
Followers 167
Posts 22620
Boards Moderated 0
Alias Born 11/01/2012

Re: None

Tuesday, 05/10/2022 10:20:24 AM

Tuesday, May 10, 2022 10:20:24 AM

Post# of 35
Therapeutics (LOGC) Chardan Capital analyst Geulah Livshits reiterated a Buy rating on Logicbio Therapeutics yesterday and set a price target of $6.00. The company's shares closed last Monday at $0.67, close to its 52-week low of $0.39. According to TipRanks.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LOGC News